News

This cross-sectional study addressed the age-old fertility question: how does underwear choice affect men's swimmers?

A team at Scripps Research has come up with a faster way to analyze the outcome of experimental vaccines against HIV and other pathogens.

Scientists have created a powerful new tool for precisely controlling the 3D architecture—also called stereochemistry—of linkages known as thiophosphates, found in some promising new drugs that target genetic molecules and other disease targets.

A uniquely designed experimental vaccine against Zika virus has proven powerful in mice, new research has found.

UC Davis researchers have shown that low levels of cytomegalovirus (CMV) have a significant impact on microbe and immune cell populations and how the immune system responds to the influenza vaccine.

A research team has developed a novel peptide drug called FFW that could potentially stop the development of hepatocellular carcinoma (HCC) or primary liver cancer.

Bioengineered lungs have been successfully transplanted into adult pigs, with remarkable results.

NISTmAb, the world's first standardized monoclonal antibody has become a valuable tool for biomanufacturers developing new biologic therapies for cancers, autoimmune disorders and infectious diseases.

Inhibiting a previously known protein could reduce tumor burdens and enhance the effectiveness of immunotherapy treatments, according to new research.

This is the first time a signaling protein has been shown to control its own transport mechanism.